Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Antimicrob Agents ; 12(2): 151-8, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10418761

RESUMO

Multiple dose pharmacokinetics of artemether and dihydroartemisinin were investigated in chinese patients treated for malaria. They received over 2 days either 4 x 80 mg artemether orally (n = 48) or 4 x 80-480 mg co-artemether (n = 40), a combination of artemether and lumefantrine (benflumetol). Lag time = 0.48 h (mean), Cmax after first dose = 157 ng/ml, t(max) = 1.73 h and elimination half-life = 1.16 h. The lag and absorption times were 0.5 h longer for co-artemether compared with artemether. Dihydroartemisinin paralleled artemether pharmacokinetics. Artemether Cmax after the last dose was one-third of the Cmax after the first dose while, inversely, dihydroartemisinin Cmax increased over time. We suggest that auto-induction of gut mucosa enzymes and/or liver enzymes causes a time-dependent increase in first-pass metabolisation of artemether.


Assuntos
Antimaláricos/farmacocinética , Artemisininas , Malária Falciparum/sangue , Sesquiterpenos/farmacocinética , Adolescente , Adulto , Antimaláricos/uso terapêutico , Artemeter , China , Método Duplo-Cego , Avaliação de Medicamentos , Quimioterapia Combinada , Etanolaminas/farmacocinética , Etanolaminas/uso terapêutico , Feminino , Fluorenos/farmacocinética , Fluorenos/uso terapêutico , Humanos , Lumefantrina , Malária Falciparum/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Modelos Químicos , Sesquiterpenos/uso terapêutico , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA